David Rizzieri Selected Research

David Rizzieri Research Topics

Disease

20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2007
19	Neoplasms (Cancer) 11/2022 - 01/2002
15	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 06/2006
7	Leukemia 01/2021 - 02/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2020
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 12/2003
6	Lymphoma (Lymphomas) 11/2021 - 09/2004
6	Multiple Myeloma 12/2017 - 02/2008
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 12/2013
5	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 06/2010
3	Thrombocytopenia (Thrombopenia) 01/2020 - 07/2012
3	Neutropenia 01/2020 - 07/2012
3	Pathologic Complete Response 01/2020 - 02/2006
3	Breast Neoplasms (Breast Cancer) 02/2006 - 01/2002
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 04/2022 - 05/2017
2	Frailty 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 12/2021 - 08/2002
2	Anemia 01/2021 - 07/2012
2	Fatigue 01/2021 - 01/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	Febrile Neutropenia 01/2020 - 07/2012
2	Pneumonia (Pneumonitis) 01/2020 - 07/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2019 - 11/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 02/2008
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2018 - 07/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013 - 02/2012
1	Invasive Fungal Infections 11/2022
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	Cognitive Dysfunction 01/2022
1	Epstein-Barr Virus Infections 12/2021
1	Inflammation (Inflammations) 01/2021
1	Blast Crisis (Blast Phase) 10/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Hypophosphatemia 01/2020
1	monosomy Chromosome 7 01/2020

Drug/Important Bio-Agent (IBA)

7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 01/2002
5	fludarabineIBA 11/2021 - 12/2007
4	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2015 - 04/2012
3	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 01/2010
3	Busulfan (Busulfex)FDA Link 11/2021 - 05/2008
3	Rituximab (Mabthera)FDA Link 10/2018 - 09/2004
3	guadecitabineIBA 01/2018 - 09/2015
3	Alkylating AgentsIBA 06/2010 - 02/2006
3	Carmustine (FIVB)FDA Link 02/2006 - 01/2002
3	Cisplatin (Platino)FDA LinkGeneric 02/2006 - 01/2002
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2021 - 01/2020
2	Histone Deacetylase InhibitorsIBA 11/2021 - 01/2017
2	AntigensIBA 01/2020 - 08/2002
2	pixantrone (BBR 2778)IBA 10/2018 - 07/2012
2	Pharmaceutical PreparationsIBA 10/2017 - 09/2015
2	5'-oleoyl cytarabineIBA 09/2014 - 04/2012
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2014 - 04/2012
2	Arsenic Trioxide (Trisenox)FDA Link 03/2013 - 06/2006
2	Bortezomib (Velcade)FDA Link 03/2013 - 01/2010
2	laromustine (VNP40101M)IBA 06/2010 - 01/2007
2	Diphtheria ToxinIBA 03/2008 - 12/2005
1	posaconazole FDA Link 11/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	thymoglobulin FDA Link 12/2021
1	Everolimus FDA Link 11/2021
1	PanobinostatIBA 11/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	danvatirsenIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	beta-DefensinsIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	durvalumabIBA 01/2021
1	tremelimumabIBA 01/2021
1	pasireotideIBA 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	nilotinib FDA Link 10/2019
1	Calcineurin InhibitorsIBA 01/2019
1	Bendamustine Hydrochloride FDA Link 10/2018
1	IpilimumabIBA 01/2018
1	Decitabine FDA Link 10/2017
1	Azacitidine (5 Azacytidine)FDA Link 10/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	mocetinostatIBA 01/2017
1	Histones (Histone)IBA 01/2017
1	acivicin (AT 125)IBA 09/2015
1	TetraspaninsIBA 08/2015

Therapy/Procedure

17	Therapeutics 11/2021 - 02/2006
16	Cell Transplantation 11/2022 - 01/2007
12	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
10	Transplantation 04/2022 - 05/2008
6	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2020
5	Stem Cell Transplantation 12/2017 - 08/2002
2	Induction Chemotherapy 11/2022 - 02/2006
2	Homologous Transplantation 11/2021 - 01/2021
2	Salvage Therapy 10/2018 - 07/2012
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2013 - 02/2006
1	Donor Selection 03/2022
1	MDC protocol 01/2022
1	Length of Stay 01/2022
1	Radioimmunotherapy 01/2019
1	Autologous Transplantation 01/2018
1	Secondary Prevention 01/2018